EUVIMEDEUVIMED entdecken
Open Access

Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults

Diya Surie, Katharine A Yuengling, Jennifer DeCuir, Yuwei Zhu, Adam S Lauring, Manjusha Gaglani, Shekhar Ghamande, Ithan D Peltan, Samuel M Brown, Adit A Ginde, Amanda Martinez, Nicholas M Mohr und 44 weitere

JAMA Network Open · 04.04.2024 · 7 (4) · e244954

DOI: 10.1001/jamanetworkopen.2024.4954 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 04.04.2024. Verfasst von Diya Surie und 55 weiteren Autor:innen. Beteiligte Einrichtung: Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Preven…. Hauptthemen laut MEDLINE: Influenza, Human, COVID-19, Influenza Vaccines, Respiratory Syncytial Virus Infections. Die Arbeit wurde bisher 98-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance On June 21, 2023, the Centers for Disease Control and Prevention recommended the first respiratory syncytial virus (RSV) vaccines for adults aged 60 years and older using shared clinical decision-making. Understanding the severity of RSV disease in adults can help guide this clinical decision-making.

Objective

To describe disease severity among adults hospitalized with RSV and compare it with the severity of COVID-19 and influenza disease by vaccination status. Design, Setting, and Participants In this cohort study, adults aged 18 years and older admitted to the hospital with acute respiratory illness and laboratory-confirmed RSV, SARS-CoV-2, or influenza infection were prospectively enrolled from 25 hospitals in 20 US states from February 1, 2022, to May 31, 2023. Clinical data during each patient’s hospitalization were collected using standardized forms. Data were analyzed from August to October 2023. Exposures RSV, SARS-CoV-2, or influenza infection. Main Outcomes and Measures Using multivariable logistic regression, severity of RSV disease was compared with COVID-19 and influenza severity, by COVID-19 and influenza vaccination status, for a range of clinical outcomes, including the composite of invasive mechanical ventilation (IMV) and in-hospital death.

Results

Of 7998 adults (median [IQR] age, 67 [54-78] years; 4047 [50.6%] female) included, 484 (6.1%) were hospitalized with RSV, 6422 (80.3%) were hospitalized with COVID-19, and 1092 (13.7%) were hospitalized with influenza. Among patients with RSV, 58 (12.0%) experienced IMV or death, compared with 201 of 1422 unvaccinated patients with COVID-19 (14.1%) and 458 of 5000 vaccinated patients with COVID-19 (9.2%), as well as 72 of 699 unvaccinated patients with influenza (10.3%) and 20 of 393 vaccinated patients with influenza (5.1%). In adjusted analyses, the odds of IMV or in-hospital death were not significantly different among patients hospitalized with RSV and unvaccinated patients hospitalized with COVID-19 (adjusted odds ratio [aOR], 0.82; 95% CI, 0.59-1.13; P = .22) or influenza (aOR, 1.20; 95% CI, 0.82-1.76; P = .35); however, the odds of IMV or death were significantly higher among patients hospitalized with RSV compared with vaccinated patients hospitalized with COVID-19 (aOR, 1.38; 95% CI, 1.02-1.86; P = .03) or influenza disease (aOR, 2.81; 95% CI, 1.62-4.86; P < .001). Conclusions and Relevance Among adults hospitalized in this US cohort during the 16 months before the first RSV vaccine recommendations, RSV disease was less common but similar in severity compared with COVID-19 or influenza disease among unvaccinated patients and more severe than COVID-19 or influenza disease among vaccinated patients for the most serious outcomes of IMV or death.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza, HumanCOVID-19Influenza VaccinesRespiratory Syncytial Virus InfectionsUnited StatesAdultHumansFemaleMiddle AgedAgedMaleRespiratory Syncytial VirusesCohort StudiesHospital MortalitySARS-CoV-2

Substanzen

Influenza Vaccines

Autor:innen und Institutionen

  • Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Department of Internal Medicine, University of Michigan, Ann Arbor.
  • Department of Microbiology and Immunology, University of Michigan, Ann Arbor.
  • Baylor Scott & White Health, Temple, Texas.
  • Texas A&M University College of Medicine, Temple.

Förderung

  • NCATS NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Surie, D., Yuengling, K. A., DeCuir, J., Zhu, Y., Lauring, A. S., Gaglani, M., Ghamande, S., Peltan, I. D., Brown, S. M., Ginde, A. A., Martinez, A., Mohr, N. M., Gibbs, K. W., Hager, D. N., Ali, H., Prekker, M. E., Gong, M. N., Mohamed, A., Johnson, N. J., …, & Investigating Respiratory Viruses in the Acutely Ill (IVY) Network (2024). Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults. JAMA Network Open, 7(4), e244954. https://doi.org/10.1001/jamanetworkopen.2024.4954

Vancouver

Surie D, Yuengling KA, DeCuir J, Zhu Y, Lauring AS, Gaglani M, et al. Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults. JAMA Network Open. 2024;7(4):e244954. doi:10.1001/jamanetworkopen.2024.4954

BibTeX
@article{Surie2024,
  author = {Surie, Diya and Yuengling, Katharine A and DeCuir, Jennifer and Zhu, Yuwei and Lauring, Adam S and Gaglani, Manjusha and Ghamande, Shekhar and Peltan, Ithan D and Brown, Samuel M and Ginde, Adit A and Martinez, Amanda and Mohr, Nicholas M and Gibbs, Kevin W and Hager, David N and Ali, Harith and Prekker, Matthew E and Gong, Michelle N and Mohamed, Amira and Johnson, Nicholas J and Srinivasan, Vasisht and Steingrub, Jay S and Leis, Aleda M and Khan, Akram and Hough, Catherine L and Bender, William S and Duggal, Abhijit and Bendall, Emily E and Wilson, Jennifer G and Qadir, Nida and Chang, Steven Y and Mallow, Christopher and Kwon, Jennie H and Exline, Matthew C and Shapiro, Nathan I and Columbus, Cristie and Vaughn, Ivana A and Ramesh, Mayur and Mosier, Jarrod M and Safdar, Basmah and Casey, Jonathan D and Talbot, H Keipp and Rice, Todd W and Halasa, Natasha and Chappell, James D and Grijalva, Carlos G and Baughman, Adrienne and Womack, Kelsey N and Swan, Sydney A and Johnson, Cassandra A and Lwin, Cara T and Lewis, Nathaniel M and Ellington, Sascha and McMorrow, Meredith L and Martin, Emily T and Self, Wesley H and Investigating Respiratory Viruses in the Acutely Ill (IVY) Network, Investigating Respiratory Viruses in the Acutely Ill (IVY) Network},
  title = {Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults},
  journal = {JAMA Network Open},
  year = {2024},
  volume = {7},
  number = {4},
  pages = {e244954},
  doi = {10.1001/jamanetworkopen.2024.4954}
}
Kostenlos starten →